 Boulter has claimed that the matter of a legal battle between Porton Group and 3M concerning Acolyte, an EU regulatory approved rapid detection technology for MRSA, and a deal worth £41 million was allocated no more than 5–10 minutes at the end of the meeting.According to "The Guardian", details relating to the nature of the visit and the business matters discussed suggest that it was "highly irregular".The MoD has stated that there were no officials present at the meeting but that one of those present claimed to have received the impression that all of those in attendance had been security cleared.